Therapy Areas: Cardiovascular
Rocket Pharmaceuticals receives FDA clearance for gene therapy targeting BAG3-associated dilated cardiomyopathy
30 June 2025 - Late-stage biotechnology company Rocket Pharmaceuticals Inc (NASDAQ:RCKT) announced on Monday that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug app...
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
26 June 2025 - Accord Healthcare Inc, a US-based generic pharmaceutical company, announced on Wednesday that it has added Dehydrated Alcohol Injection to its line of cardiovascular drugs.Accord's...
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
25 June 2025 - Innovent Biologics Inc (HKEX: 01801), a China-based biopharmaceutical company that develops, manufactures and commercialises medicines for the treatment of oncology, autoimmune, cardiov...
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
25 June 2025 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International that markets, distributes and sells generic medicines in the United States, announced on Tuesday tha...
Cumberland Pharmaceuticals reports ifetroban Phase 2 DMD heart disease trial results
24 June 2025 - Cumberland Pharmaceuticals Inc (NASDAQ: CPIX), a US-based specialty pharmaceutical company, on Monday announced the latest positive results from its Phase 2 FIGHT DMD trial evaluating i...
EDX Medical and Spire Healthcare sign strategic diagnostic partnership agreement
16 June 2025 - EDX Medical Group plc (AQSE: EDX), a developer of digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular disease and infectious diseases,...